Jorge Ibanez-Vega

5PUBLICATIONS
41CO-AUTHORS
Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 30, 2026
RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGs.

Jorge Ibanez-Vega, Robert Teis, Jennifer K Ocasio

|Jun 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response.

Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan

|Nov 30, 2023
Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling.

Matthew Bell, Shannon Lange, Besian I Sejdiu

|Nov 16, 2023
CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity.

Dalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford

|Feb 02, 2023
Synapse-tuned CARs enhance immune cell anti-tumor activity.

Peter J Chockley, Jorge Ibanez-Vega, Giedre Krenciute

Pageof 1